NLRP3 and tauopathy: In the present study, we evaluated the efficacy of targeting both NF-κB and NLRP3 in brain aging and tauopathy by treating both old wildtype mice and transgenic rTg4510 mice (a model of tauopathy commonly used in neurodegeneration research) with our Nanoligomer cocktail.